Sarah A. Cooley, MD

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Sarah A. Cooley

Contact Info

Mailing Address:
Division of Hematology, Oncology and Transplantation
420 Delaware Street SE
MMC 480
Minneapolis, MN 55455

Administrative Assistant Name
Stephanie Weiland

Administrative Phone
612-626-4024

Administrative Email
matur015@umn.edu

Administrative Fax Number
612-625-6919

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Affiliate Faculty, Institute for Health Informatics (IHI)


Hematologist / Oncologist


Medical School, University of Minnesota, Minneapolis, MN

Internal Medicine Residency, University of California, San Francisco, CA

Hematology, Oncology and Transplantation Fellowship, University of Minnesota, Minneapolis, MN

Summary

Dr. Cooley received bachelor’s degrees in biology and chemistry from Cornell University in 1994. She spent two years working for the American Red Cross National HLA Reference Laboratory in Rockville, Maryland before attending medical school at the University of Minnesota. Her internal medicine residency was completed at the University of California, San Francisco in 2003, when she returned to Minnesota for the fellowship program in Hematology, Oncology and Transplantation. In 2006, she became an Assistant Professor in the Division of Hematology, Oncology and Transplantation.

Awards & Recognition

  • Cecil J. Watson Award, Minnesota Medical Foundation, 2006
  • Medical Student Achievement Award, Minnesota Medical Foundation, 2000

Professional Associations

  • Associate Director, Cancer Experimental Therapeutics Initiative, 2008 - present
  • Alpha Omega Alpha

Research

Publications

  • Warlick ED, Tomblyn M, Cao Q, Defor T, Blazar BR, Macmillan M, Verneris M, Wagner J, Dusenbery K, Aurora M, Bachanova V, Brunstein C, Burns L, Cooley S, Kaufman D, Majhail NS, McClune B, McGlave P, Miller J, Oran B, Slungaard A, Vercellotti G, Weisdorf DJ. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-hodgkin lymphomas. Biol Blood Marrow Transplant. 2011 Jul;17(7):1025-32. Epub 2010 Nov 1.
  • Bachanova V, Burns LJ, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lindgren BR, Cooley S, Weisdorf D, Miller JS. Allogeneic natural killer cells for refractory lymphoma. Cancer Immunol Immunother. 2010 Nov;59(11):1739-44. Epub 2010 Aug 3.
  • Geller MA, Cooley S, Judson PL, Ghebre R, Carson LF, Argenta PA, Jonson AL, Panoskaltsis-Mortari A, Curtsinger J, McKenna D, Dusenbery K, Bliss R, Downs LS, Miller JS. A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy. 2011 Jan;13(1):98-107. Epub 2010 Sep 20.
  • Cooley S, Weisdorf DS. Natural killer cells and tumor control. Curr Opin Hematol. 2010 Nov;17(6):514-21.
  • Geller MA, Cooley S, Argenta PA, Downs LS, Carson LF, Judson PL, Ghebre R, Weigel B, Panoskaltsis-Mortari A, Curtsinger J, Miller JS. Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers. Cancer Immunol Immunother. 2010 Dec;59(12):1877-84. Epub 2010 Sep 5.

Clinical

Specialties

  • Blood and Marrow Transplant Surgery
  • Cancer

Clinics

Blood and Marrow Transplant (BMT) Clinic

Board Certifications

  • Internal Medicine, Oncology, Hematology

Clinical Interests

Blood and Marrow Transplantation

Hospital Privileges

Fairview Lakes Medical Center; Fairview Northland Medical Center; Fairview Southdale Hospital; University of Minnesota Medical Center; Fairview